_id
691050ddccc777a4e85d5426
Ticker
CMMB
Name
Chemomab Therapeutics Ltd DRC
Exchange
NASDAQ
Address
Building 7, Tel Aviv, Israel, 6158002
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.chemomab.com
Description
Chemomab Therapeutics Ltd., a clinical-stage biotechnology company, focuses on the discovery and development of therapeutics for the treatment of fibrotic and inflammatory diseases in the United States. Its lead product candidate is Nebokitug, a humanized monoclonal antibody attenuates the basic function of CCL24 that has completed phase 2 clinical trial for the treatment of primary sclerosing cholangitis (PSC); and is in phase 2 clinical trial to treat systemic sclerosis (SSc). Chemomab Therapeutics Ltd. was founded in 2011 and is based in Tel Aviv, Israel.
Last Close
1.64
Volume
110552
Current Price
1.87
Change
0.01
Last Updated
2026-01-02T11:36:55.746Z
Image
data:image/webp;base64,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
Ipo Date
2019-02-12T00:00:00.000Z
Market Cap
10155943
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
0.823
Sentiment Sources
1
Rating
4.5
Target Price
17.5
Strong Buy
1
Buy
1
Hold
0
Sell
0
Strong Sell
0
Current Quarter
2025-09-30
Revenue
0
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
1844000
Operating Income
-1844000
Interest Expense
-
Pretax Income
-1742000
Net Income
-1742000
Eps
-0.28191210200751515
Dividends Per Share
-
Shares Outstanding
6155117
Income Tax Expense
-
EBITDA
-1844000
Operating Margin
-
Total Other Income Expense Net
102000
Cash
6974000
Short Term Investments
3082000
Receivables
1721000
Inventories
-
Total Current Assets
11926000
Property Plant Equipment
188000
Total Assets
12368000
Payables
194000
Short Term Debt
-
Long Term Debt
-
Total Liabilities
1137000
Equity
11231000
Bs_currency_symbol
USD
Depreciation
13250
Change In Working Capital
-
Cash From Operations
-
Capital Expenditures
0
Cash From Investing
-
Cash From Financing
-
Net Change In Cash
1526946
Cf_currency_symbol
USD
PE
-
PB
1.0288631439764937
ROE
-15.510640192324814
ROA
-14.084734799482534
FCF
-
Fcf Percent
-
Piotroski FScore
0
Health Score
42
Deep Value Investing Score
6
Defensive Investing Score
7
Dividend Investing Score
1.5
Economic Moat Investing Score
3.8
Garp Investing Score
2
Growth Investing Score
0.5
Momentum Investing Score
2
Net Net Investing Score
5.5
Quality Investing Score
2.5
Value Investing Score
6.5
Quarters > 0 > quarter
2025-09-30
Quarters > 0 > income Statement > revenue
0
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
1844000
Quarters > 0 > income Statement > operating Income
-1844000
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-1742000
Quarters > 0 > income Statement > net Income
-1742000
Quarters > 0 > income Statement > eps
-0.28191210200751515
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
6179231
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-1844000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
102000
Quarters > 0 > income Statement > currency_symbol
USD
Quarters > 0 > balance Sheet > cash
6974000
Quarters > 0 > balance Sheet > short Term Investments
3082000
Quarters > 0 > balance Sheet > receivables
1721000
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
11926000
Quarters > 0 > balance Sheet > property Plant Equipment
188000
Quarters > 0 > balance Sheet > total Assets
12368000
Quarters > 0 > balance Sheet > payables
194000
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
1137000
Quarters > 0 > balance Sheet > equity
11231000
Quarters > 0 > balance Sheet > currency_symbol
USD
Quarters > 0 > cash Flow > net Income
-1750147
Quarters > 0 > cash Flow > depreciation
13250
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
-
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-
Quarters > 0 > cash Flow > cash From Financing
-
Quarters > 0 > cash Flow > net Change In Cash
1526946
Quarters > 0 > cash Flow > currency_symbol
USD
Quarters > 0 > ratios > PE
-0.28191210200751515
Quarters > 0 > ratios > PB
1.0288631439764937
Quarters > 0 > ratios > ROE
-15.510640192324814
Quarters > 0 > ratios > ROA
-14.084734799482534
Quarters > 0 > ratios > FCF
-
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
42
Quarters > 1 > quarter
2025-06-30
Quarters > 1 > income Statement > revenue
0
Quarters > 1 > income Statement > cost Of Revenue
33687
Quarters > 1 > income Statement > gross Profit
-33687
Quarters > 1 > income Statement > operating Expenses
2262000
Quarters > 1 > income Statement > operating Income
-2262000
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-2057000
Quarters > 1 > income Statement > net Income
-2057000
Quarters > 1 > income Statement > eps
-0.35503126070099084
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
5793856
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-2066161
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
205000
Quarters > 1 > income Statement > currency_symbol
USD
Quarters > 1 > balance Sheet > cash
5448000
Quarters > 1 > balance Sheet > short Term Investments
3917000
Quarters > 1 > balance Sheet > receivables
1101000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
10614000
Quarters > 1 > balance Sheet > property Plant Equipment
217000
Quarters > 1 > balance Sheet > total Assets
11129000
Quarters > 1 > balance Sheet > payables
378000
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
1430000
Quarters > 1 > balance Sheet > equity
9699000
Quarters > 1 > balance Sheet > currency_symbol
USD
Quarters > 1 > cash Flow > net Income
-2099848
Quarters > 1 > cash Flow > depreciation
33687
Quarters > 1 > cash Flow > change In Working Capital
-
Quarters > 1 > cash Flow > cash From Operations
-
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-
Quarters > 1 > cash Flow > cash From Financing
-
Quarters > 1 > cash Flow > net Change In Cash
-2882058
Quarters > 1 > cash Flow > currency_symbol
USD
Quarters > 1 > ratios > PE
-0.35503126070099084
Quarters > 1 > ratios > PB
1.1170750304155068
Quarters > 1 > ratios > ROE
-21.208371997113105
Quarters > 1 > ratios > ROA
-18.483241980411538
Quarters > 1 > ratios > FCF
-
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
42
Quarters > 2 > quarter
2025-03-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
3487000
Quarters > 2 > income Statement > operating Income
-3487000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-3323000
Quarters > 2 > income Statement > net Income
-3323000
Quarters > 2 > income Statement > eps
-0.58279095307805
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
5701873
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-3473750
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
164000
Quarters > 2 > income Statement > currency_symbol
USD
Quarters > 2 > balance Sheet > cash
8338000
Quarters > 2 > balance Sheet > short Term Investments
2225000
Quarters > 2 > balance Sheet > receivables
1274000
Quarters > 2 > balance Sheet > inventories
1
Quarters > 2 > balance Sheet > total Current Assets
11977000
Quarters > 2 > balance Sheet > property Plant Equipment
501000
Quarters > 2 > balance Sheet > total Assets
12819000
Quarters > 2 > balance Sheet > payables
490000
Quarters > 2 > balance Sheet > short Term Debt
113000
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
2426000
Quarters > 2 > balance Sheet > equity
10393000
Quarters > 2 > balance Sheet > currency_symbol
USD
Quarters > 2 > cash Flow > net Income
-3305736
Quarters > 2 > cash Flow > depreciation
13250
Quarters > 2 > cash Flow > change In Working Capital
-
Quarters > 2 > cash Flow > cash From Operations
-
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
-
Quarters > 2 > cash Flow > net Change In Cash
2331131
Quarters > 2 > cash Flow > currency_symbol
USD
Quarters > 2 > ratios > PE
-0.58279095307805
Quarters > 2 > ratios > PB
1.0259311565476765
Quarters > 2 > ratios > ROE
-31.97344366400462
Quarters > 2 > ratios > ROA
-25.922458850144313
Quarters > 2 > ratios > FCF
-
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
42
Quarters > 3 > quarter
2024-12-31
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
3213000
Quarters > 3 > income Statement > operating Income
-3213000
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-2963000
Quarters > 3 > income Statement > net Income
-2963000
Quarters > 3 > income Statement > eps
-0.15713321974982672
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
18856611
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-3196250
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
250000
Quarters > 3 > income Statement > currency_symbol
USD
Quarters > 3 > balance Sheet > cash
6071000
Quarters > 3 > balance Sheet > short Term Investments
8195000
Quarters > 3 > balance Sheet > receivables
-
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
16040000
Quarters > 3 > balance Sheet > property Plant Equipment
539000
Quarters > 3 > balance Sheet > total Assets
16964000
Quarters > 3 > balance Sheet > payables
666000
Quarters > 3 > balance Sheet > short Term Debt
115000
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
3427000
Quarters > 3 > balance Sheet > equity
13537000
Quarters > 3 > balance Sheet > currency_symbol
USD
Quarters > 3 > cash Flow > net Income
-2963000
Quarters > 3 > cash Flow > depreciation
16750
Quarters > 3 > cash Flow > change In Working Capital
-
Quarters > 3 > cash Flow > cash From Operations
-
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
-
Quarters > 3 > cash Flow > net Change In Cash
-
Quarters > 3 > cash Flow > currency_symbol
USD
Quarters > 3 > ratios > PE
-0.15713321974982672
Quarters > 3 > ratios > PB
2.6048505998374827
Quarters > 3 > ratios > ROE
-21.888158380734286
Quarters > 3 > ratios > ROA
-17.466399434095734
Quarters > 3 > ratios > FCF
-
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
42
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
53251
Annuals > 0 > income Statement > gross Profit
-53251
Annuals > 0 > income Statement > operating Expenses
14739000
Annuals > 0 > income Statement > operating Income
-14739000
Annuals > 0 > income Statement > interest Expense
-
Annuals > 0 > income Statement > pretax Income
-13945000
Annuals > 0 > income Statement > net Income
-13945000
Annuals > 0 > income Statement > eps
-3.1071006105692223
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
4488107
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-13957934
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
794000
Annuals > 0 > income Statement > currency_symbol
USD
Annuals > 0 > balance Sheet > cash
6071000
Annuals > 0 > balance Sheet > short Term Investments
8195000
Annuals > 0 > balance Sheet > receivables
263000
Annuals > 0 > balance Sheet > inventories
1
Annuals > 0 > balance Sheet > total Current Assets
16040000
Annuals > 0 > balance Sheet > property Plant Equipment
539000
Annuals > 0 > balance Sheet > total Assets
16964000
Annuals > 0 > balance Sheet > payables
666000
Annuals > 0 > balance Sheet > short Term Debt
229999
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
3427000
Annuals > 0 > balance Sheet > equity
13537000
Annuals > 0 > balance Sheet > currency_symbol
USD
Annuals > 0 > cash Flow > net Income
-14011185
Annuals > 0 > cash Flow > depreciation
53251
Annuals > 0 > cash Flow > change In Working Capital
-2121019
Annuals > 0 > cash Flow > cash From Operations
-15459024
Annuals > 0 > cash Flow > capital Expenditures
4.96
Annuals > 0 > cash Flow > cash From Investing
2307902
Annuals > 0 > cash Flow > cash From Financing
9914835
Annuals > 0 > cash Flow > net Change In Cash
-3221057
Annuals > 0 > cash Flow > currency_symbol
USD
Annuals > 0 > ratios > PE
-3.1071006105692223
Annuals > 0 > ratios > PB
0.5470470968456822
Annuals > 0 > ratios > ROE
-103.01396173450543
Annuals > 0 > ratios > ROA
-82.20348974298514
Annuals > 0 > ratios > FCF
-15459028.96
Annuals > 0 > ratios > Piotroski FScore
1
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
34
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
66827
Annuals > 1 > income Statement > gross Profit
-66827
Annuals > 1 > income Statement > operating Expenses
25459000
Annuals > 1 > income Statement > operating Income
-25459000
Annuals > 1 > income Statement > interest Expense
-
Annuals > 1 > income Statement > pretax Income
-24221000
Annuals > 1 > income Statement > net Income
-24221000
Annuals > 1 > income Statement > eps
-8.245488913134876
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
2937485
Annuals > 1 > income Statement > income Tax Expense
-1
Annuals > 1 > income Statement > EBITDA
-25392000
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
1238000
Annuals > 1 > income Statement > currency_symbol
USD
Annuals > 1 > balance Sheet > cash
9292000
Annuals > 1 > balance Sheet > short Term Investments
10492000
Annuals > 1 > balance Sheet > receivables
289000
Annuals > 1 > balance Sheet > inventories
-1037005
Annuals > 1 > balance Sheet > total Current Assets
20897000
Annuals > 1 > balance Sheet > property Plant Equipment
695000
Annuals > 1 > balance Sheet > total Assets
22151000
Annuals > 1 > balance Sheet > payables
516000
Annuals > 1 > balance Sheet > short Term Debt
152000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
5154000
Annuals > 1 > balance Sheet > equity
16997000
Annuals > 1 > balance Sheet > currency_symbol
USD
Annuals > 1 > cash Flow > net Income
-24158586
Annuals > 1 > cash Flow > depreciation
66827
Annuals > 1 > cash Flow > change In Working Capital
-945557
Annuals > 1 > cash Flow > cash From Operations
-23550158
Annuals > 1 > cash Flow > capital Expenditures
2991
Annuals > 1 > cash Flow > cash From Investing
15838082
Annuals > 1 > cash Flow > cash From Financing
3494970
Annuals > 1 > cash Flow > net Change In Cash
-4228110
Annuals > 1 > cash Flow > currency_symbol
USD
Annuals > 1 > ratios > PE
-8.245488913134876
Annuals > 1 > ratios > PB
0.28515916044007766
Annuals > 1 > ratios > ROE
-142.50161793257635
Annuals > 1 > ratios > ROA
-109.34495056656584
Annuals > 1 > ratios > FCF
-23553149
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
33
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
57773
Annuals > 2 > income Statement > gross Profit
-57773
Annuals > 2 > income Statement > operating Expenses
28533000
Annuals > 2 > income Statement > operating Income
-28533000
Annuals > 2 > income Statement > interest Expense
353000
Annuals > 2 > income Statement > pretax Income
-28180000
Annuals > 2 > income Statement > net Income
-27646000
Annuals > 2 > income Statement > eps
-9.717856658274941
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
2844866
Annuals > 2 > income Statement > income Tax Expense
-534000
Annuals > 2 > income Statement > EBITDA
-28475000
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
353000
Annuals > 2 > income Statement > currency_symbol
USD
Annuals > 2 > balance Sheet > cash
13519000
Annuals > 2 > balance Sheet > short Term Investments
26374000
Annuals > 2 > balance Sheet > receivables
459000
Annuals > 2 > balance Sheet > inventories
-
Annuals > 2 > balance Sheet > total Current Assets
41736000
Annuals > 2 > balance Sheet > property Plant Equipment
594000
Annuals > 2 > balance Sheet > total Assets
43063000
Annuals > 2 > balance Sheet > payables
1688000
Annuals > 2 > balance Sheet > short Term Debt
123000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
6840000
Annuals > 2 > balance Sheet > equity
36223000
Annuals > 2 > balance Sheet > currency_symbol
USD
Annuals > 2 > cash Flow > net Income
-27537828
Annuals > 2 > cash Flow > depreciation
57773
Annuals > 2 > cash Flow > change In Working Capital
3991321
Annuals > 2 > cash Flow > cash From Operations
-20290297
Annuals > 2 > cash Flow > capital Expenditures
67732
Annuals > 2 > cash Flow > cash From Investing
19456572
Annuals > 2 > cash Flow > cash From Financing
-804838
Annuals > 2 > cash Flow > net Change In Cash
-47565698
Annuals > 2 > cash Flow > currency_symbol
USD
Annuals > 2 > ratios > PE
-9.717856658274941
Annuals > 2 > ratios > PB
0.12958697236562405
Annuals > 2 > ratios > ROE
-76.32167407448306
Annuals > 2 > ratios > ROA
-64.19896430810674
Annuals > 2 > ratios > FCF
-20358029
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
33
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
34023
Annuals > 3 > income Statement > gross Profit
-34023
Annuals > 3 > income Statement > operating Expenses
12367000
Annuals > 3 > income Statement > operating Income
-12367000
Annuals > 3 > income Statement > interest Expense
111076
Annuals > 3 > income Statement > pretax Income
-12478000
Annuals > 3 > income Statement > net Income
-12478000
Annuals > 3 > income Statement > eps
-4.811522358270628
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
2593358
Annuals > 3 > income Statement > income Tax Expense
77000
Annuals > 3 > income Statement > EBITDA
-12333000
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-111000
Annuals > 3 > income Statement > currency_symbol
USD
Annuals > 3 > balance Sheet > cash
14686000
Annuals > 3 > balance Sheet > short Term Investments
45975000
Annuals > 3 > balance Sheet > receivables
179000
Annuals > 3 > balance Sheet > inventories
-1348019
Annuals > 3 > balance Sheet > total Current Assets
62688000
Annuals > 3 > balance Sheet > property Plant Equipment
702000
Annuals > 3 > balance Sheet > total Assets
64353000
Annuals > 3 > balance Sheet > payables
1336000
Annuals > 3 > balance Sheet > short Term Debt
212000
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
2887000
Annuals > 3 > balance Sheet > equity
61466000
Annuals > 3 > balance Sheet > currency_symbol
USD
Annuals > 3 > cash Flow > net Income
-12486635
Annuals > 3 > cash Flow > depreciation
34023
Annuals > 3 > cash Flow > change In Working Capital
-1950348
Annuals > 3 > cash Flow > cash From Operations
-12382563
Annuals > 3 > cash Flow > capital Expenditures
239166
Annuals > 3 > cash Flow > cash From Investing
-45217270
Annuals > 3 > cash Flow > cash From Financing
61116265
Annuals > 3 > cash Flow > net Change In Cash
55769844
Annuals > 3 > cash Flow > currency_symbol
USD
Annuals > 3 > ratios > PE
-4.811522358270628
Annuals > 3 > ratios > PB
0.0696163846679465
Annuals > 3 > ratios > ROE
-20.300654020108677
Annuals > 3 > ratios > ROA
-19.389927431510575
Annuals > 3 > ratios > FCF
-12621729
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
33
Valuation > metrics > PE
-0.28191210200751515
Valuation > metrics > PB
1.0288631439764937
Valuation > final Score
80
Valuation > verdict
Fair
Profitability > metrics > ROE
-15.510640192324814
Profitability > metrics > ROA
-14.606741573033707
Profitability > final Score
15
Profitability > verdict
Weak
Risk > metrics > Debt Equity
0.10123764580179859
Risk > metrics > Interest Coverage
-18.07843137254902
Risk > final Score
-12
Risk > verdict
High
Liquidity > metrics > Current Ratio
61.47422680412371
Liquidity > metrics > Quick Ratio
61.47422680412371
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
80
Prev Valuations > 1
80
Prev Valuations > 2
80
Prev Profitabilities > 0
15
Prev Profitabilities > 1
15
Prev Profitabilities > 2
15
Prev Risks > 0
-928
Prev Risks > 1
-33
Prev Risks > 2
5
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T21:37:19.327Z
Earnings History > 0 > period
2025-09-30
Earnings History > 0 > report Date
2025-11-07
Earnings History > 0 > date
2025-09-30
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
-0.004
Earnings History > 0 > eps Estimate
-0.005
Earnings History > 0 > eps Difference
0.001
Earnings History > 0 > surprise Percent
20
Earnings History > 1 > period
2025-06-30
Earnings History > 1 > report Date
2025-08-14
Earnings History > 1 > date
2025-06-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
-0.016
Earnings History > 1 > eps Estimate
-0.1
Earnings History > 1 > eps Difference
0.084
Earnings History > 1 > surprise Percent
84
Earnings History > 2 > period
2025-03-31
Earnings History > 2 > report Date
2025-05-07
Earnings History > 2 > date
2025-03-31
Earnings History > 2 > before After Market
BeforeMarket
Earnings History > 2 > currency
USD
Earnings History > 2 > eps Actual
-0.007
Earnings History > 2 > eps Estimate
-0.01
Earnings History > 2 > eps Difference
0.003
Earnings History > 2 > surprise Percent
30
Earnings History > 3 > period
2024-12-31
Earnings History > 3 > report Date
2025-03-05
Earnings History > 3 > date
2024-12-31
Earnings History > 3 > before After Market
BeforeMarket
Earnings History > 3 > currency
USD
Earnings History > 3 > eps Actual
-0.008
Earnings History > 3 > eps Estimate
-0.01
Earnings History > 3 > eps Difference
0.002
Earnings History > 3 > surprise Percent
20
Earnings History > 4 > period
2024-09-30
Earnings History > 4 > report Date
2024-11-14
Earnings History > 4 > date
2024-09-30
Earnings History > 4 > before After Market
BeforeMarket
Earnings History > 4 > currency
USD
Earnings History > 4 > eps Actual
-0.01
Earnings History > 4 > eps Estimate
-0.01
Earnings History > 4 > eps Difference
0
Earnings History > 4 > surprise Percent
0
Earnings History > 5 > period
2024-06-30
Earnings History > 5 > report Date
2024-08-21
Earnings History > 5 > date
2024-06-30
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.26
Earnings History > 5 > eps Estimate
-0.01
Earnings History > 5 > eps Difference
-0.25
Earnings History > 5 > surprise Percent
-2500
Earnings History > 6 > period
2024-03-31
Earnings History > 6 > report Date
2024-05-09
Earnings History > 6 > date
2024-03-31
Earnings History > 6 > before After Market
BeforeMarket
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.2753
Earnings History > 6 > eps Estimate
-0.03
Earnings History > 6 > eps Difference
-0.2453
Earnings History > 6 > surprise Percent
-817.6667
Earnings History > 7 > period
2023-12-31
Earnings History > 7 > report Date
2024-03-07
Earnings History > 7 > date
2023-12-31
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.2654
Earnings History > 7 > eps Estimate
-0.02
Earnings History > 7 > eps Difference
-0.2454
Earnings History > 7 > surprise Percent
-1227
Earnings History > 8 > period
2023-09-30
Earnings History > 8 > report Date
2023-11-09
Earnings History > 8 > date
2023-09-30
Earnings History > 8 > before After Market
BeforeMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.02
Earnings History > 8 > eps Estimate
-0.02
Earnings History > 8 > eps Difference
0
Earnings History > 8 > surprise Percent
0
Earnings History > 9 > period
2023-06-30
Earnings History > 9 > report Date
2023-08-14
Earnings History > 9 > date
2023-06-30
Earnings History > 9 > before After Market
BeforeMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
-0.036
Earnings History > 9 > eps Estimate
-0.03
Earnings History > 9 > eps Difference
-0.006
Earnings History > 9 > surprise Percent
-20
Earnings History > 10 > period
2023-03-31
Earnings History > 10 > report Date
2023-05-11
Earnings History > 10 > date
2023-03-31
Earnings History > 10 > before After Market
BeforeMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.8
Earnings History > 10 > eps Estimate
-0.04
Earnings History > 10 > eps Difference
-0.76
Earnings History > 10 > surprise Percent
-1900
Earnings History > 11 > period
2022-12-31
Earnings History > 11 > report Date
2023-03-20
Earnings History > 11 > date
2022-12-31
Earnings History > 11 > before After Market
BeforeMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.04
Earnings History > 11 > eps Estimate
-0.04
Earnings History > 11 > eps Difference
0
Earnings History > 11 > surprise Percent
0
Earnings History > 12 > period
2022-09-30
Earnings History > 12 > report Date
2022-11-11
Earnings History > 12 > date
2022-09-30
Earnings History > 12 > before After Market
BeforeMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.04
Earnings History > 12 > eps Estimate
-0.33
Earnings History > 12 > eps Difference
0.29
Earnings History > 12 > surprise Percent
87.8788
Earnings History > 13 > period
2022-06-30
Earnings History > 13 > report Date
2022-08-12
Earnings History > 13 > date
2022-06-30
Earnings History > 13 > before After Market
BeforeMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.54
Earnings History > 13 > eps Estimate
-0.25
Earnings History > 13 > eps Difference
-0.29
Earnings History > 13 > surprise Percent
-116
Earnings History > 14 > period
2022-03-31
Earnings History > 14 > report Date
2022-05-12
Earnings History > 14 > date
2022-03-31
Earnings History > 14 > before After Market
BeforeMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.44
Earnings History > 14 > eps Estimate
-0.24
Earnings History > 14 > eps Difference
-0.2
Earnings History > 14 > surprise Percent
-83.3333
Earnings History > 15 > period
2021-12-31
Earnings History > 15 > report Date
2022-03-09
Earnings History > 15 > date
2021-12-31
Earnings History > 15 > before After Market
BeforeMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.44
Earnings History > 15 > eps Estimate
-0.1
Earnings History > 15 > eps Difference
-0.34
Earnings History > 15 > surprise Percent
-340
Earnings History > 16 > period
2021-09-30
Earnings History > 16 > report Date
2021-11-12
Earnings History > 16 > date
2021-09-30
Earnings History > 16 > before After Market
BeforeMarket
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.26
Earnings History > 16 > eps Estimate
-0.14
Earnings History > 16 > eps Difference
-0.12
Earnings History > 16 > surprise Percent
-85.7143
Earnings History > 17 > period
2021-06-30
Earnings History > 17 > report Date
2021-08-13
Earnings History > 17 > date
2021-06-30
Earnings History > 17 > before After Market
BeforeMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.26
Earnings History > 17 > eps Estimate
-0.11
Earnings History > 17 > eps Difference
-0.15
Earnings History > 17 > surprise Percent
-136.3636
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-05-13
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
BeforeMarket
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.22
Earnings History > 18 > eps Estimate
-0.43
Earnings History > 18 > eps Difference
0.21
Earnings History > 18 > surprise Percent
48.8372
Earnings History > 19 > period
2020-12-31
Earnings History > 19 > report Date
2021-03-09
Earnings History > 19 > date
2020-12-31
Earnings History > 19 > before After Market
AfterMarket
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.06
Earnings History > 19 > eps Estimate
-1.6
Earnings History > 19 > eps Difference
1.54
Earnings History > 19 > surprise Percent
96.25
Earnings History > 20 > period
2020-09-30
Earnings History > 20 > report Date
2020-11-16
Earnings History > 20 > date
2020-09-30
Earnings History > 20 > before After Market
BeforeMarket
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.09
Earnings History > 20 > eps Estimate
-0.09
Earnings History > 20 > eps Difference
0
Earnings History > 20 > surprise Percent
0
Earnings History > 21 > period
2020-06-30
Earnings History > 21 > report Date
2020-08-14
Earnings History > 21 > date
2020-06-30
Earnings History > 21 > before After Market
BeforeMarket
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.09
Earnings History > 21 > eps Estimate
-0.11
Earnings History > 21 > eps Difference
0.02
Earnings History > 21 > surprise Percent
18.1818
Earnings History > 22 > period
2020-03-31
Earnings History > 22 > report Date
2020-05-07
Earnings History > 22 > date
2020-03-31
Earnings History > 22 > before After Market
AfterMarket
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-8
Earnings History > 22 > eps Estimate
-1.84
Earnings History > 22 > eps Difference
-6.16
Earnings History > 22 > surprise Percent
-334.7826
Earnings History > 23 > period
2019-12-31
Earnings History > 23 > report Date
2020-03-17
Earnings History > 23 > date
2019-12-31
Earnings History > 23 > before After Market
BeforeMarket
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
31.2
Earnings History > 23 > eps Estimate
-2
Earnings History > 23 > eps Difference
33.2
Earnings History > 23 > surprise Percent
1660
Earnings History > 24 > period
2019-09-30
Earnings History > 24 > report Date
2019-11-15
Earnings History > 24 > date
2019-09-30
Earnings History > 24 > before After Market
BeforeMarket
Earnings History > 24 > currency
USD
Earnings History > 24 > eps Actual
-34.4
Earnings History > 24 > eps Estimate
-2.93
Earnings History > 24 > eps Difference
-31.47
Earnings History > 24 > surprise Percent
-1074.0614
Earnings History > 25 > period
2019-06-30
Earnings History > 25 > report Date
2019-08-05
Earnings History > 25 > date
2019-06-30
Earnings History > 25 > before After Market
AfterMarket
Earnings History > 25 > currency
USD
Earnings History > 25 > eps Actual
-4
Earnings History > 25 > eps Estimate
-2.64
Earnings History > 25 > eps Difference
-1.36
Earnings History > 25 > surprise Percent
-51.5152
Earnings History > 26 > period
2019-03-31
Earnings History > 26 > report Date
2019-05-22
Earnings History > 26 > date
2019-03-31
Earnings History > 26 > before After Market
AfterMarket
Earnings History > 26 > currency
USD
Earnings History > 26 > eps Actual
-56
Earnings History > 26 > eps Estimate
-2.56
Earnings History > 26 > eps Difference
-53.44
Earnings History > 26 > surprise Percent
-2087.5
Earnings History > 27 > period
2018-12-31
Earnings History > 27 > report Date
2019-03-12
Earnings History > 27 > date
2018-12-31
Earnings History > 27 > before After Market
AfterMarket
Earnings History > 27 > currency
USD
Earnings History > 27 > eps Actual
-0.12
Earnings History > 27 > eps Estimate
-0.15
Earnings History > 27 > eps Difference
0.03
Earnings History > 27 > surprise Percent
20
Chemomab Therapeutics Ltd., a clinical-stage biotechnology company, focuses on the discovery and development of therapeutics for the treatment of fibrotic and inflammatory diseases in the United States. Its lead product candidate is Nebokitug, a humanized monoclonal antibody attenuates the basic function of CCL24 that has completed phase 2 clinical trial for the treatment of primary sclerosing cholangitis (PSC); and is in phase 2 clinical trial to treat systemic sclerosis (SSc). Chemomab Therapeutics Ltd. was founded in 2011 and is based in Tel Aviv, Israel.
Stock Price
$0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/AHead-To-Head Survey: Zenas BioPharma (NASDAQ:ZBIO) vs. Chemomab Therapeutics (NASDAQ:CMMB) Defense World
Read more →Trading Recap: Is CMMB stock a top performer YTD - Market Activity Recap & Safe Entry Trade Signal Reports baoquankhu1.vn
Read more →Showing 2 of 10
(Last Updated 2025-09-30)
Rating:
STRONG BUY
Target Price:
$17.5
Analyst Picks
Strong Buy
1
Buy
1
Hold
0
Sell
0
Strong Sell
0
Sentiment:
Bullish
(Last Updated 2025-09-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very Low
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
Debt to Equity
-
Very High
Low ≥ 1
High ≤ 0.3
* Institutions hold a combined 0.00% of the total shares of Chemomab Therapeutics Ltd DRC
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2025-09-30
EPS Actual
-0.004
EPS Estimate
-0.005
EPS Difference
0.001
Surprise Percent
20%
(Last Updated 2025-09-30)
(Last Updated 2025-09-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-09-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-09-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.